Evoke Pharma's total assets for Q3 2025 were $15.65M, a decrease of -2.56% from the previous quarter. EVOK total liabilities were $12.29M for the fiscal quarter, a 5.15% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.